Franklin Resources Inc Neuronetics, Inc. Transaction History

Franklin Resources Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $6,960 - $13,802	-2,962 Reduced 3.4%	84,226 $268,000
Q2 2022 Aug 11, 2022	BUY	$2.09 - $3.71 $4 - $7	2 Added 0.0%	87,188 $280,000
Q1 2022 May 13, 2022	BUY	$2.84 - $4.52 $247,608 - $394,080	87,186 New	87,186 $264,000
Q1 2020 May 13, 2020	SELL	$1.28 - $4.5 $376,500 - $1.32 Million	-294,141 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$4.03 - $9.22 $487,061 - $1.11 Million	-120,859 Reduced 29.12%	294,141 $1.32 Million

Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $6,300 - $12,040	-700 Reduced 0.17%	415,000 $5.19 Million
Q1 2019 May 14, 2019	SELL	$13.6 - $19.58 $1.51 Million - $2.17 Million	-111,024 Reduced 21.08%	415,700 $6.34 Million
Q4 2018 Feb 12, 2019	BUY	$16.0 - $31.84 $1.83 Million - $3.63 Million	114,124 Added 27.66%	526,724 $10.2 Million
Q3 2018 Nov 13, 2018	BUY	$24.32 - $37.54 $2.41 Million - $3.73 Million	99,300 Added 31.69%	412,600 $13.2 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $8.34 Million - $8.7 Million	313,300 New	313,300 $8.34 Million

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.